BG102707A - New triazolopurinpurines, method for their preparation and appplication as medicamentous forms - Google Patents
New triazolopurinpurines, method for their preparation and appplication as medicamentous formsInfo
- Publication number
- BG102707A BG102707A BG102707A BG10270798A BG102707A BG 102707 A BG102707 A BG 102707A BG 102707 A BG102707 A BG 102707A BG 10270798 A BG10270798 A BG 10270798A BG 102707 A BG102707 A BG 102707A
- Authority
- BG
- Bulgaria
- Prior art keywords
- new
- preparation
- triazolopurinpurines
- appplication
- receptors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19629378A DE19629378A1 (de) | 1996-07-20 | 1996-07-20 | Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
PCT/EP1997/003841 WO1998003511A1 (fr) | 1996-07-20 | 1997-07-17 | Nouvelles triazolopurines, procede pour les preparer et leur utilisation comme medicaments |
CA002242097A CA2242097C (fr) | 1996-07-20 | 1998-06-26 | Imidazotriazolopyrimidines, procedes pour les preparer, et leur utilisation en tant que compositions pharmaceutiques |
Publications (1)
Publication Number | Publication Date |
---|---|
BG102707A true BG102707A (en) | 1999-09-30 |
Family
ID=32963000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG102707A Pending BG102707A (en) | 1996-07-20 | 1998-08-20 | New triazolopurinpurines, method for their preparation and appplication as medicamentous forms |
Country Status (25)
Country | Link |
---|---|
EP (2) | EP0880524B1 (fr) |
JP (1) | JP3020281B2 (fr) |
CN (1) | CN1219936A (fr) |
AT (1) | ATE191913T1 (fr) |
AU (1) | AU3695597A (fr) |
BG (1) | BG102707A (fr) |
BR (1) | BR9710747A (fr) |
CA (1) | CA2256736A1 (fr) |
CZ (1) | CZ265498A3 (fr) |
DE (2) | DE19629378A1 (fr) |
DK (1) | DK0880524T3 (fr) |
EE (1) | EE9800451A (fr) |
ES (1) | ES2147453T3 (fr) |
GR (1) | GR3033842T3 (fr) |
HR (1) | HRP970395A2 (fr) |
HU (1) | HUP9902311A3 (fr) |
ID (1) | ID19106A (fr) |
IL (1) | IL126453A0 (fr) |
NO (1) | NO983860L (fr) |
PL (1) | PL328824A1 (fr) |
PT (1) | PT880524E (fr) |
SK (1) | SK114498A3 (fr) |
TR (1) | TR199801659T2 (fr) |
WO (1) | WO1998003511A1 (fr) |
ZA (1) | ZA976331B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19826843A1 (de) * | 1998-06-16 | 1999-12-23 | Boehringer Ingelheim Pharma | Neue Imidazotriazolopyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US6492377B1 (en) | 1998-06-25 | 2002-12-10 | Boehringer Ingelheim Pharma Kg | Imidazotriazolopyrimidines with adenosine-antagonistic activity |
AU9347498A (en) * | 1998-08-27 | 2000-03-21 | Boehringer Ingelheim Pharma Kg | Imidazotriazolopyrimidines |
US7329668B2 (en) | 2003-02-25 | 2008-02-12 | Bristol-Myers Squibb Company | Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
US7071333B2 (en) | 2003-07-30 | 2006-07-04 | Bristol-Myers Squibb Company | Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
EP2044074A2 (fr) * | 2006-06-23 | 2009-04-08 | Incyte Corporation | Dérivés de purinone en tant qu'agonistes du hm74a |
CN112384515A (zh) | 2018-02-27 | 2021-02-19 | 因赛特公司 | 作为a2a/a2b抑制剂的咪唑并嘧啶和三唑并嘧啶 |
MX2020012376A (es) | 2018-05-18 | 2021-03-09 | Incyte Corp | Derivados de pirimidina fusionados como inhibidores de los receptores de adenosina a2a/a2b. |
TWI829857B (zh) | 2019-01-29 | 2024-01-21 | 美商英塞特公司 | 作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶 |
CN112778311A (zh) * | 2019-11-01 | 2021-05-11 | 上海翰森生物医药科技有限公司 | 含氮并环类衍生物抑制剂、其制备方法和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU623755B2 (en) * | 1989-03-29 | 1992-05-21 | Merrell Pharmaceuticals Inc. | Selective adenosine receptor compounds |
IT1264901B1 (it) * | 1993-06-29 | 1996-10-17 | Schering Plough S P A | Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina |
JPH083169A (ja) * | 1994-06-15 | 1996-01-09 | Yamasa Shoyu Co Ltd | 4−メチル−1H−[1,2,4]トリアゾロ[1,5−a]プリン−9(4H)−オン類 |
-
1996
- 1996-07-20 DE DE19629378A patent/DE19629378A1/de not_active Withdrawn
-
1997
- 1997-07-17 PL PL97328824A patent/PL328824A1/xx unknown
- 1997-07-17 DK DK97933683T patent/DK0880524T3/da active
- 1997-07-17 TR TR1998/01659T patent/TR199801659T2/xx unknown
- 1997-07-17 ZA ZA976331A patent/ZA976331B/xx unknown
- 1997-07-17 HU HU9902311A patent/HUP9902311A3/hu unknown
- 1997-07-17 DE DE59701467T patent/DE59701467D1/de not_active Expired - Lifetime
- 1997-07-17 PT PT97933683T patent/PT880524E/pt unknown
- 1997-07-17 BR BR9710747A patent/BR9710747A/pt unknown
- 1997-07-17 EE EE9800451A patent/EE9800451A/xx unknown
- 1997-07-17 WO PCT/EP1997/003841 patent/WO1998003511A1/fr not_active Application Discontinuation
- 1997-07-17 JP JP10505626A patent/JP3020281B2/ja not_active Expired - Fee Related
- 1997-07-17 SK SK1144-98A patent/SK114498A3/sk unknown
- 1997-07-17 AU AU36955/97A patent/AU3695597A/en not_active Abandoned
- 1997-07-17 ES ES97933683T patent/ES2147453T3/es not_active Expired - Lifetime
- 1997-07-17 AT AT97933683T patent/ATE191913T1/de active
- 1997-07-17 CA CA002256736A patent/CA2256736A1/fr not_active Abandoned
- 1997-07-17 EP EP97933683A patent/EP0880524B1/fr not_active Expired - Lifetime
- 1997-07-17 IL IL12645397A patent/IL126453A0/xx unknown
- 1997-07-17 CN CN97194506A patent/CN1219936A/zh active Pending
- 1997-07-17 EP EP99119410A patent/EP0978517A3/fr not_active Withdrawn
- 1997-07-17 CZ CZ982654A patent/CZ265498A3/cs unknown
- 1997-07-18 ID IDP972495A patent/ID19106A/id unknown
- 1997-07-18 HR HR19629378.2A patent/HRP970395A2/hr not_active Application Discontinuation
-
1998
- 1998-08-20 BG BG102707A patent/BG102707A/xx active Pending
- 1998-08-21 NO NO983860A patent/NO983860L/no not_active Application Discontinuation
-
2000
- 2000-06-30 GR GR20000401543T patent/GR3033842T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
BR9710747A (pt) | 1999-08-17 |
WO1998003511A1 (fr) | 1998-01-29 |
ZA976331B (en) | 1999-01-25 |
AU3695597A (en) | 1998-02-10 |
NO983860D0 (no) | 1998-08-21 |
SK114498A3 (en) | 1999-02-11 |
ID19106A (id) | 1998-06-18 |
EP0880524A1 (fr) | 1998-12-02 |
DK0880524T3 (da) | 2000-07-17 |
PL328824A1 (en) | 1999-02-15 |
GR3033842T3 (en) | 2000-10-31 |
HRP970395A2 (en) | 1998-08-31 |
CN1219936A (zh) | 1999-06-16 |
NO983860L (no) | 1998-10-21 |
EP0978517A2 (fr) | 2000-02-09 |
TR199801659T2 (xx) | 1998-12-21 |
IL126453A0 (en) | 1999-08-17 |
CA2256736A1 (fr) | 1998-01-29 |
JP2000501420A (ja) | 2000-02-08 |
EE9800451A (et) | 1999-06-15 |
DE19629378A1 (de) | 1998-01-29 |
CZ265498A3 (cs) | 1998-12-16 |
EP0978517A3 (fr) | 2003-11-12 |
HUP9902311A2 (hu) | 1999-10-28 |
JP3020281B2 (ja) | 2000-03-15 |
ATE191913T1 (de) | 2000-05-15 |
PT880524E (pt) | 2000-07-31 |
ES2147453T3 (es) | 2000-09-01 |
DE59701467D1 (de) | 2000-05-25 |
HUP9902311A3 (en) | 2000-06-28 |
EP0880524B1 (fr) | 2000-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG103740A (en) | Phytostyrene composition for the prevention of the alzheimer's disease | |
MD1745B2 (en) | 4,5-dimethyl-N-2-propenyl-2-(trimethylsilyl)-3-thiophencarboxamide, fungicidal composition on base thereof and method of plants diseases control | |
AU4347796A (en) | Use of nebivolol as an anti-atherogenic | |
UA66750C2 (en) | Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors | |
BG104315A (en) | Prostaglandine agonists and their application for the treatment of osteal diseases | |
BG102616A (en) | Substituted aza- and diazacycloheptane and cyclooctane derivatives and their application | |
MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
CA2272584A1 (fr) | Nouveaux derives de pyrazole substitues pour le traitement de maladies cardio-vasculaires | |
BG101131A (en) | 2-oxo-and 2-thio-1,2-dihydroquinolinyl-oxazolidinons | |
BG101901A (en) | 2-methyl-thieno-benzodiazepine formulation for oral application | |
UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
MY132529A (en) | Paroxetine hydrochloride anhydrate | |
EP0793660A4 (fr) | 1,1-dioxydes de 1,2,5-thiadiazolidin-3-one substitues en position 2, compositions et procede d'utilisation | |
BG103219A (en) | Benzamidine derivatives and their application as medicamentous forms with ltb-4-antagonist effect | |
BG102623A (en) | New derivatives of benzoylguanadine, methods for their preparation and application for the manufacture of medicamentous forms | |
BG102707A (en) | New triazolopurinpurines, method for their preparation and appplication as medicamentous forms | |
ATE82127T1 (de) | N-acetylglucosamin-zubereitungen zur buccalen anwendung. | |
BG105275A (en) | Tan-1057 derivatives | |
MX9704034A (es) | Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso. | |
BG102814A (en) | New derivatives of carboxylic acid, their preparation and application | |
BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
BG102667A (en) | Diosgenine-containing composition | |
BG103649A (en) | Method for the preparation of eprosartan | |
BG103650A (en) | Method for the preparation of eprosartan | |
PL331321A1 (en) | Treatment pf psychotic disorders |